» Articles » PMID: 38904041

Association Between Triglyceride Glucose Index and Breast Cancer in 142,184 Chinese Adults: Findings from the REACTION Study

Abstract

Background: The triglyceride glucose (TyG) index has been associated with an increased risk in breast cancer. However, this association remains unclear among the Chinese population. This study aimed to investigate whether the TyG index is associated with the risk of prevalent breast cancer in Chinese women.

Methods: This cross-sectional study included 142,184 women from the REACTION (Risk Evaluation of Cancers in Chinese Diabetic Individuals: A Longitudinal) Study, which recruited adults aged 40 years or older from 25 centers across mainland China between 2011 and 2012. The TyG index was calculated according to the formula: Ln (fasting triglycerides [mg/dL] × fasting glucose [mg/dL]/2). Multivariable-adjusted logistic regression models were used to evaluate odds ratios (ORs) and 95% confidence intervals (CIs) regarding the associations between the TyG index and breast cancer.

Results: Multivariable-adjusted logistic regression analysis showed that compared with the lowest quartile of the TyG index, the highest quartile of the TyG index was significantly associated with an increased risk of prevalent breast cancer, with an OR (95% CI) of 1.61 (1.19-2.17). In the stratified analysis, the association of each 1 SD increase in the TyG index with risk of prevalent breast cancer was more dominant in individuals with menarche at age 13-17, those who were postmenopausal, those with a history of breastfeeding, and those who had two to four children, with the ORs (95% CIs) of 1.35 (1.09-1.68), 1.27 (1.05-1.54), 1.26 (1.05-1.52), and 1.32 (1.08-1.62), respectively. Moreover, among those without discernible insulin resistance (homeostatic model assessment-insulin resistance [HOMA-IR] ≥2.5), hyperglycemia and dyslipidemia, each 1 SD increase in the TyG index was associated with a 1.36-fold increase in breast cancer risk, with an OR (95% CI) of 2.36 (1.44-3.87).

Conclusion: The TyG index is significantly associated with the prevalent breast cancer risk among middle-aged and elderly Chinese women.

Citing Articles

The mediating role of the TyG index in the relationship between circadian syndrome and cancer among middle-aged and elderly Chinese.

Bai Z, Liang J, Nie Y, Wang S, Chang D BMC Cancer. 2025; 25(1):431.

PMID: 40065285 PMC: 11895363. DOI: 10.1186/s12885-025-13816-7.


Association of Triglycerides and HbA1c Levels with Stages of Invasive Ductal Breast Cancer: A Prospective Study.

Helena V, Suresh A, Muninathan N, Baskaran K, Khan S J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4559-S4562.

PMID: 40061778 PMC: 11888739. DOI: 10.4103/jpbs.jpbs_1217_24.


Associations between triglyceride-glucose related indices and the risk of incident pancreatic cancer: a large-scale prospective cohort study in the UK Biobank.

Wu Z, Yang J, Ma Z, Chen Y, Han M, Wu Q BMC Cancer. 2025; 25(1):327.

PMID: 39984911 PMC: 11846352. DOI: 10.1186/s12885-025-13718-8.


Triglyceride-glucose index and triglyceride-glucose-body mass index as prognostic factors for early stage breast cancer patients receiving neoadjuvant chemotherapy.

Li F, Gao T, Li Z, Dou H, Ba Y, Jia S Transl Oncol. 2025; 53:102292.

PMID: 39884219 PMC: 11814653. DOI: 10.1016/j.tranon.2025.102292.


The associations of physical activity patterns and the triglyceride-glucose index in US adults: a secondary data analysis of NHANES (2007-2018).

Zhang J, Yang Y, Zheng H, Bai B, Yang Q, Zhang L Sci Rep. 2025; 15(1):2375.

PMID: 39827230 PMC: 11742976. DOI: 10.1038/s41598-025-86278-3.

References
1.
Araujo A, Abaurrea A, Azcoaga P, Lopez-Velazco J, Manzano S, Rodriguez J . Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment. J Clin Invest. 2022; 132(7). PMC: 8970678. DOI: 10.1172/JCI148667. View

2.
Ozkan B, Ndumele C . Addressing Cardiovascular Risk in Diabetes: It's More Than the Sugar. Circulation. 2023; 147(25):1887-1890. DOI: 10.1161/CIRCULATIONAHA.123.065090. View

3.
Biello F, Platini F, DAvanzo F, Cattrini C, Mennitto A, Genestroni S . Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights. Biomolecules. 2021; 11(1). PMC: 7835955. DOI: 10.3390/biom11010125. View

4.
Jung S, Papp J, Sobel E, Yu H, Zhang Z . Breast Cancer Risk and Insulin Resistance: Post Genome-Wide Gene-Environment Interaction Study Using a Random Survival Forest. Cancer Res. 2019; 79(10):2784-2794. PMC: 6522308. DOI: 10.1158/0008-5472.CAN-18-3688. View

5.
Zhang J, Yin B, Xi Y, Bai Y . Triglyceride-glucose index is a risk factor for breast cancer in China: a cross-sectional study. Lipids Health Dis. 2024; 23(1):29. PMC: 10811843. DOI: 10.1186/s12944-024-02008-0. View